CN1/C(=C\C(=O)C[n+]2cccc(C(N)=O)c2)C(C)(C)c2ccccc21.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?